HALEY MURPHY: Open Payments
NPI 1891279030 · EUPORA, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,442 in 120 payments from 17 companies in 2025. Trend: 2023 $345 · 2024 $1,474 · 2025 $2,442
Food & beverage: $2,442
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $409 |
| GlaxoSmithKline, LLC. | 31 | $406 |
| Viatris Specialty LLC | 21 | $361 |
| Inspire Medical Systems, Inc. | 6 | $222 |
| GENZYME CORPORATION | 10 | $194 |
| Grifols USA, LLC | 7 | $158 |
| Insmed, Inc. | 6 | $126 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $117 |
| JAZZ PHARMACEUTICALS INC. | 4 | $98 |
| HARMONY BIOSCIENCES LLC | 3 | $69 |
Products named: YUPELRI, DUPIXENT, INSPIRE, TEZSPIRE, NUCALA, TRELEGY ELLIPTA, Prolastin-C Liquid, Arikayce.
Industry payments across MS — which companies pay providers there.
